1
|
Krikunova PV, Tolordava ER, Arkharova NA, Karimov DN, Bukreeva TV, Shirinian VZ, Khaydukov EV, Pallaeva TN. Riboflavin Crystals with Extremely High Water Solubility. ACS APPLIED MATERIALS & INTERFACES 2024; 16:5504-5512. [PMID: 38278768 DOI: 10.1021/acsami.3c15853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/28/2024]
Abstract
New insights into the unique biochemical properties of riboflavin (Rf), also known as vitamin B2, are leading to the development of its use not only as a vitamin supplement but also as a potential anti-inflammatory, immunomodulatory, antioxidant, anticancer, and antiviral agent, where it may play a role as an inhibitor of viral proteinases. At the same time, the comparison of the pharmacoactivity of Rf with its known metabolites, namely, flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), is very complicated due to its poor water solubility: 0.1-0.3 g/L versus 67 g/L for FMN and 50 g/L for FAD, which is the limiting factor for its administration in clinical practice. In this study, we report the recrystallization procedure of the type A Rf crystals into the slightly hydrophobic type B/C and a new hydrophilic crystal form that has been termed the P type. Our method of Rf crystal modification based on recrystallization from dilute alkaline solution provides an unprecedented extremely high water solubility of Rf, reaching 23.5 g/L. A comprehensive study of the physicochemical properties of type P riboflavin showed increased photodynamic therapeutic activity compared to the known types A and B/C against clinical isolates of Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, and Salmonella typhimurium. Importantly, our work not only demonstrates a simple and inexpensive method for the synthesis of riboflavin with high solubility, which should lead to increased bioactivity, but also opens up opportunities for improving both known and new therapeutic applications of vitamin B2.
Collapse
Affiliation(s)
| | - Eteri R Tolordava
- Gamaleya Research Institute of Epidemiology and Microbiology, Moscow 123098, Russia
| | | | - Denis N Karimov
- FSRC "Crystallography and Photonics" RAS, Moscow 119333, Russia
| | | | - Valerii Z Shirinian
- N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow 119991, Russia
| | | | | |
Collapse
|
2
|
Marincean S, Nichols DL, Benore MA. Riboflavin interactions with the chicken isolated carrier protein. Bioorg Med Chem Lett 2023; 96:129529. [PMID: 37858620 DOI: 10.1016/j.bmcl.2023.129529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2023] [Accepted: 10/16/2023] [Indexed: 10/21/2023]
Abstract
Riboflavin, a member of the B vitamin family, is a water-soluble vitamin that participates in energy metabolism processes via two coenzymes, flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), in oxidized and reduced forms. Low levels of riboflavin have been associated with growth and developmental problems. In an effort to investigate the role of hydrogen bonding in the interactions between riboflavin and chicken riboflavin binding protein, the solid state geometry characteristics of a riboflavin derivative stripped of hydroxyl groups except the primary one, N-(6'-hydroxyhexyl)isoalloxazine, were investigated and found that π-stacking and hydrogen bonding involving the isoalloxazine rings are the primary intermolecular interactions. Subsequent comparative fluorescence studies showed that at neutral pH, in presence of the protein, quenching of N-(6'-hydroxyhexyl)isoalloxazine and riboflavin occurred similarly suggesting that the hydroxyl groups were not a key component of the vitamin protein interactions in the binding pocket.
Collapse
Affiliation(s)
- Simona Marincean
- Department of Natural Sciences, University of Michigan-Dearborn, 4901 Evergreen Rd, Dearborn, MI 48128, USA.
| | - Diana L Nichols
- Department of Natural Sciences, University of Michigan-Dearborn, 4901 Evergreen Rd, Dearborn, MI 48128, USA
| | - Marilee A Benore
- Department of Natural Sciences, University of Michigan-Dearborn, 4901 Evergreen Rd, Dearborn, MI 48128, USA
| |
Collapse
|
3
|
Henaff C, Siepmann J, Siepmann F, Danède F, Avettand-Fènoël MN, Vérin J, Fadel A, Willart JF. Exploration of the physical states of riboflavin (free base) by mechanical milling. Int J Pharm 2023; 645:123416. [PMID: 37716485 DOI: 10.1016/j.ijpharm.2023.123416] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2023] [Revised: 09/11/2023] [Accepted: 09/12/2023] [Indexed: 09/18/2023]
Abstract
Amorphous riboflavin (free base) could be produced for the first time via high energy ball milling of a commercial crystalline form (Form I). Importantly, this solid state amorphization process allowed to circumvent chemical degradation occurring during melting as well as the lack of suitable solvents, which are required for amorphization via spray- or freeze-drying. The amorphous state of riboflavin was thoroughly characterized, revealing a complex recrystallization pattern upon heating, involving two enantiotropic polymorphic forms (II and III) and a dihydrate. The glass transition temperature (Tg) and heat capacity (Cp) jump of the amorphous form were determined as 144 °C and 0.68 J/g/°C. Moreover, the relative physical stability of the different physical states has been elucidated, e.g., at room temperature: I > II > III. The following rank order was observed for the dissolution rates in water at 37 °C during the first 4 h: amorphous > III ≈ II > I. Afterwards, a dihydrate crystallized from the solutions of amorphous and metastable crystalline riboflavin forms, the solubility of which was well above the solubility of the stable FormI.
Collapse
Affiliation(s)
- C Henaff
- Univ. Lille, CNRS, INRAE, Centrale Lille, UMR 8207 UMET - Unité Matériaux et Transformations F-59000 Lille, France; Univ. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France
| | - J Siepmann
- Univ. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France
| | - F Siepmann
- Univ. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France
| | - F Danède
- Univ. Lille, CNRS, INRAE, Centrale Lille, UMR 8207 UMET - Unité Matériaux et Transformations F-59000 Lille, France
| | - M-N Avettand-Fènoël
- Univ. Lille, CNRS, INRAE, Centrale Lille, UMR 8207 UMET - Unité Matériaux et Transformations F-59000 Lille, France
| | - J Vérin
- Univ. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France
| | - A Fadel
- Univ. Lille, CNRS, INRAE, Centrale Lille, Univ. Artois, FR 2638 - IMEC - Institut Michel-Eugène Chevreul, F-59000 Lille, France
| | - J-F Willart
- Univ. Lille, CNRS, INRAE, Centrale Lille, UMR 8207 UMET - Unité Matériaux et Transformations F-59000 Lille, France.
| |
Collapse
|